Skip to main content
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2003 Oct;12(5):309–313. doi: 10.1080/09629350310001619753

Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity.

Sharon E Jacob 1, Mehdi Nassiri 1, Francisco A Kerdel 1, Vladimir Vincek 1
PMCID: PMC1781622  PMID: 14760939

Abstract

BACKGROUND: Psoriatic plaques have been shown to contain increased levels of proinflammatory cytokines. Serum levels of interleukin (IL)-6, IL-7, IL-8, and interferon (IFN)-gamma have been reported elevated in psoriatic patients. AIM: To evaluate serum cytokine profiles in psoriasis patients by improved enzyme-linked immunosorbent assay (ELISA) technique and to correlate these levels with disease severity. METHODS: We analyzed single serum samples from 10 patients with active untreated psoriasis, two patients with active treated psoriasis, and five healthy volunteers for major T helper type 1 and T helper type 2 cytokines using the LINCOplex ELISA multi-analyte detection system that permits simultaneous detection of multiple cytokines from a single sample. The disease severity, including erythema, induration, scale, and surface area, was assessed. RESULTS: IFN-gamma was markedly elevated in all sera from psoriasis patients, 33.8 +/- 1.3 pg/ml (mean +/- standard error) versus 8 +/- 1.5 pg/ml for normal controls (p < 0.01), and positively correlated with all indices of disease severity (Spearman r > 0.6). IL-8 was also increased in psoriasis patients (24.4 +/- 1.8 pg/ml) versus normal controls (3.6 +/- 1.2 pg/ml) (p < 0.05) and positively correlated with the degree of erythema (Spearman r > 0.6). Mean IL-12 levels were decreased in sera from psoriasis patients (8.5 +/- 1.2 pg/ml) compared with normal controls (42.2 +/- 5.3 pg/ml) (p < 0.01). Also, serum IL-10 levels were below detection levels in psoriatics compared with controls (6.4 +/- 1.3 pg/ml). CONCLUSIONS: This new ELISA system allowed rapid and reliable detection of numerous cytokines in single serum samples from patients with psoriasis. We observed that IFN-gamma and IL-8 cytokines were elevated in psoriatics and correlated with parameters of disease severity while IL-10 and IL-12 were decreased.

Full Text

The Full Text of this article is available as a PDF (92.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Elder J. T. Cytokine and genetic regulation of psoriasis. Adv Dermatol. 1995;10:99–134. [PubMed] [Google Scholar]
  2. Elkayam O., Yaron I., Shirazi I., Yaron M., Caspi D. Serum levels of IL-10, IL-6, IL-1ra, and sIL-2R in patients with psoriatic arthritis. Rheumatol Int. 2000;19(3):101–105. doi: 10.1007/s002960050111. [DOI] [PubMed] [Google Scholar]
  3. Gomi T., Shiohara T., Munakata T., Imanishi K., Nagashima M. Interleukin 1 alpha, tumor necrosis factor alpha, and interferon gamma in psoriasis. Arch Dermatol. 1991 Jun;127(6):827–830. [PubMed] [Google Scholar]
  4. Hildesheim Allan, Ryan Rick L., Rinehart Elizabeth, Nayak Sonali, Wallace Dora, Castle Philip E., Niwa Shelley, Kopp William. Simultaneous measurement of several cytokines using small volumes of biospecimens. Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1477–1484. [PubMed] [Google Scholar]
  5. Le Vine M. J., White H. A., Parrish J. A. Components of the Goeckerman regimen. J Invest Dermatol. 1979 Aug;73(2):170–173. doi: 10.1111/1523-1747.ep12581626. [DOI] [PubMed] [Google Scholar]
  6. McInnes I. B., Illei G. G., Danning C. L., Yarboro C. H., Crane M., Kuroiwa T., Schlimgen R., Lee E., Foster B., Flemming D. IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis. J Immunol. 2001 Oct 1;167(7):4075–4082. doi: 10.4049/jimmunol.167.7.4075. [DOI] [PubMed] [Google Scholar]
  7. Pietrzak A., Kozioł-Montewka M., Lecewicz-Toruń B., Krasowska D. Is there any correlation between the total number of neutrophils in plasma and concentration of interleukin-8 in psoriatic patients? Med Sci Monit. 2000 Sep-Oct;6(5):867–870. [PubMed] [Google Scholar]
  8. Shimizu T., Nishihira J., Mizue Y., Nakamura H., Abe R., Watanabe H., Ohkawara A., Shimizu H. High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasis. J Invest Dermatol. 2001 Jun;116(6):989–990. doi: 10.1046/j.0022-202x.2001.01366.x. [DOI] [PubMed] [Google Scholar]
  9. Shimizu Tadamichi, Nishihira Jun, Mizue Yuka, Nakamura Hideki, Abe Riichiro, Watanabe Hirokazu, Ishibashi Teruo, Shimizu Hiroshi. Histochemical analysis of macrophage migration inhibitory factor in psoriasis vulgaris. Histochem Cell Biol. 2002 Jul 4;118(3):251–257. doi: 10.1007/s00418-002-0435-x. [DOI] [PubMed] [Google Scholar]
  10. Szepietowski J. C., Bielicka E., Nockowski P., Noworolska A., Wasik F. Increased interleukin-7 levels in the sera of psoriatic patients: lack of correlations with interleukin-6 levels and disease intensity. Clin Exp Dermatol. 2000 Nov;25(8):643–647. doi: 10.1046/j.1365-2230.2000.00727.x. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES